Essential mixed cryoglobulinemia type II

被引:0
作者
Rozin, A. P.
Lewin, M.
Braun-Moscovici, Y.
Itzhak, O. B.
Bergman, R.
Balbir-Gurman, A.
机构
[1] Rambam Med Ctr, Dept Rheumatol, IL-31096 Haifa, Israel
[2] Rambam Med Ctr, Dept Nephrol, IL-31096 Haifa, Israel
[3] Rambam Med Ctr, Dept Pathol, IL-31096 Haifa, Israel
[4] Rambam Med Ctr, Dept Dermatol, IL-31096 Haifa, Israel
[5] Technion Israel Inst Technol, B Rapport Fac Med, Haifa, Israel
关键词
essential mixed cryoglobulinemia type II; membranous proliferative glomerulonephritis type I; ramipril; colchicine; low antigen content diet; Coombs positive hemolytic anemia;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report a rare case of essential mixed cryoglobulinemia type H with membrano-proliferative glomerulonephritis (MPGN) type I in which HCV was not found. Long-term history of palindromic rheumatism, skin leukocytoclastic vasculitis attacks and micronormocytic anemia preceded the appearance of cryoglobulinemia. Cryoprecipitate consisted of monoclonal IgMkRF and polyclonal IgG (essential mixed type II). The newly appreciated cryoglobulinemia was associated with Coombs positive hemolytic anemia. The MPGN in this case had a benign course and responded to complex simple therapies including prevention of exposure to cold, low antigen content diet, treatment of provoking factors such as UTI, and maximal dose of ACE inhibitor Responsiveness of skin vasculitis to colchicine therapy was restored after a two-month colchicine withdrawal period and therefore corticosteroid and immunosuppressive therapy was postponed.
引用
收藏
页码:329 / 332
页数:4
相关论文
共 10 条
  • [1] Occult hepatitis C virus infection in type II mixed cryoglobulinaemia
    Casato, M
    Lilli, D
    Donato, G
    Granata, M
    Conti, V
    Del Giudice, G
    Rivanera, D
    Scagnolari, C
    Antonelli, G
    Fiorilli, M
    [J]. JOURNAL OF VIRAL HEPATITIS, 2003, 10 (06) : 455 - 459
  • [2] Di Stasio E, 2004, CLIN CHEM LAB MED, V42, P614
  • [3] DOLCHER MP, 1994, CLIN EXP IMMUNOL, V96, P317
  • [4] Kidney and liver involvement in cryoglobulinemia
    Fabrizi, F
    Colucci, P
    Ponticelli, C
    Locatelli, F
    [J]. SEMINARS IN NEPHROLOGY, 2002, 22 (04) : 309 - 318
  • [5] Ferri C, 2003, CLIN EXP RHEUMATOL, V21, pS78
  • [6] FERRI C, 1989, AM J MED, V87, P519, DOI 10.1016/S0002-9343(89)80607-2
  • [7] FORNASIERI A, 1993, LAB INVEST, V69, P531
  • [8] Mechanisms of renal damage in mixed cryoglobulinaemia nephritis
    Migliorini, P
    Pratesi, F
    Moscato, S
    Bongiorni, F
    Bombardieri, S
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 58 - 59
  • [9] TAVONI A, 1995, CLIN EXP RHEUMAT S13, V13, P191
  • [10] Efficacy and safety of rituximab in type II mixed cryoglobulinemia
    Zaja, F
    De Vita, S
    Mazzaro, C
    Sacco, S
    Damiani, D
    De Marchi, G
    Michelutti, A
    Baccarani, M
    Fanin, R
    Ferraccioli, G
    [J]. BLOOD, 2003, 101 (10) : 3827 - 3834